Cargando…
Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update
In March 2020, when coronavirus disease 2019 (COVID-19) was just beginning to spread around the world, we presented the potential benefits and controversies of anti-inflammatory therapy in COVID-19 patients based on the limited experience and proposed some types of anti-inflammatory drugs with poten...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040414/ https://www.ncbi.nlm.nih.gov/pubmed/35477027 http://dx.doi.org/10.1016/j.clim.2022.109022 |